Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)
EXECUTIVE SUMMARY
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Animal Antibiotics and Antimicrobials Market on the basis of Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others), Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others); By Type of Animals (Farm Animals, Companion Animals), By Region (North America, Europe, Europe and Others) and By Country (U.S., Canada, U.K., Germany, France, China, India and Japan).
Over the recent years, the global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
According to Azoth Analytics research report “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)” global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 – 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.
Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.
The report titled, “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)” has covered and analysed the potential of Global Animal Antibiotics & Antimicrobials Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global animal antibiotics & antimicrobials market. Additionally, the report also highlights market entry strategies for various companies across the globe.
SCOPE OF THE REPORT
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Animal Antibiotics and Antimicrobials Market on the basis of Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others), Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others); By Type of Animals (Farm Animals, Companion Animals), By Region (North America, Europe, Europe and Others) and By Country (U.S., Canada, U.K., Germany, France, China, India and Japan).
Over the recent years, the global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
According to Azoth Analytics research report “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)” global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 – 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.
Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.
The report titled, “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)” has covered and analysed the potential of Global Animal Antibiotics & Antimicrobials Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global animal antibiotics & antimicrobials market. Additionally, the report also highlights market entry strategies for various companies across the globe.
SCOPE OF THE REPORT
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Global Animal Antibiotics and Antimicrobials Market, By Value
- By Product Type - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others)
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Type of Animals - Farm Animals, Companion Animals
- Animal Antibiotics and Antimicrobials Market, By Value
- Animal Antibiotics & Antimicrobials Market, By Product, By Value
- Animal Antibiotics & Antimicrobials Market, By Delivery Type, By Value
- Animal Antibiotics & Antimicrobials Market, By Type of Animals, By Value
- Animal Antibiotics & Antimicrobials Market, By Value
- Animal Antibiotics & Antimicrobials Market, By Product Type, By Value
- Animal Antibiotics & Antimicrobials Market, By Delivery Type, By Value
- Animal Antibiotics & Antimicrobials Market, By Type of Animals, By Value
- Market Dynamics – Trends, Drivers, Challenges, Policy and Regulation, Company Analysis – Bayer AG, Merck & Co., Inc., Dechra Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Eli Lilly and Company, Phibro Animal Health Corporation, Ceva Sante Animale, Virbac, Vetoquinol S.A., Zoetis, Inc.
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. GLOBAL ANTIBIOTICS & ANTIMICROBIALS PRODUCT OUTLOOK
5. GLOBAL ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections, By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)
6. NORTH AMERICA ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
6.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.3. North America Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.4. North America Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.4.1. Penicillins, By Value (2012-2022)
6.4.2. Fluoroquinolones, By Value (2012-2022)
6.4.3. Aminoglycosides, By Value (2012-2022)
6.4.4. Tetracyclines, By Value (2012-2022)
6.4.5. Macrolides, By Value (2012-2022)
6.4.6. Sulfonamides, By Value (2012-2022)
6.4.7. Lincosamides, By Value (2012-2022)
6.4.8. Cephalosporins, By Value (2012-2022)
6.4.9. Others, By Value (2012-2022)
6.5. North America Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.5.1. Farm Animals, By Value (2012-2022)
6.5.2. Companion Animals, By Value (2012-2022)
6.6. North America Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.6.1. Premixes, By Value (2012-2022)
6.6.2. Oral Powder, By Value (2012-2022)
6.6.3. Oral Solution, By Value (2012-2022)
6.6.4. Injections, By Value (2012-2022)
6.6.5. Others, By Value (2012-2022)
6.7. North America Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
6.7.1. North America Medical Gas Market, Country Share, 2012-2016 (% of Total)
6.7.2. North America Medical Gas Market, Country Share, 2017-2022 (% of Total)
6.8. U.S. Antibiotics & Antimicrobials Market: Growth and Forecast
6.8.1. U.S. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.8.2. U.S. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.9. U.S. Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.10. U.S. Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.10.1. Penicillins, By Value (2012-2022)
6.10.2. Fluoroquinolones, By Value (2012-2022)
6.10.3. Aminoglycosides, By Value (2012-2022)
6.10.4. Tetracyclines, By Value (2012-2022)
6.10.5. Macrolides, By Value (2012-2022)
6.10.6. Sulfonamides, By Value (2012-2022)
6.10.7. Lincosamides, By Value (2012-2022)
6.10.8. Cephalosporins, By Value (2012-2022)
6.10.9. Others, By Value (2012-2022)
6.11. U.S. Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.11.1. Farm Animals, By Value (2012-2022)
6.11.2. Companion Animals, By Value (2012-2022)
6.12. U.S. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.12.1. Premixes, By Value (2012-2022)
6.12.2. Oral Powder, By Value (2012-2022)
6.12.3. Oral Solution, By Value (2012-2022)
6.12.4. Injections, By Value (2012-2022)
6.12.5. Others, By Value (2012-2022)
6.13. Canada Antibiotics & Antimicrobials Market: Growth and Forecast
6.13.1. Canada Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.13.2. Canada Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.14. Canada Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.15. Canada Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.15.1. Penicillins, By Value (2012-2022)
6.15.2. Fluoroquinolones, By Value (2012-2022)
6.15.3. Aminoglycosides, By Value (2012-2022)
6.15.4. Tetracyclines, By Value (2012-2022)
6.15.5. Macrolides, By Value (2012-2022)
6.15.6. Sulfonamides, By Value (2012-2022)
6.15.7. Lincosamides, By Value (2012-2022)
6.15.8. Cephalosporins, By Value (2012-2022)
6.15.9. Others, By Value (2012-2022)
6.16. Canada Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.16.1. Farm Animals, By Value (2012-2022)
6.16.2. Companion Animals, By Value (2012-2022)
6.17. Canada Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.17.1. Premixes, By Value (2012-2022)
6.17.2. Oral Powder, By Value (2012-2022)
6.17.3. Oral Solution, By Value (2012-2022)
6.17.4. Injections, By Value (2012-2022)
6.17.5. Others, By Value (2012-2022)
7. EUROPE ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
7.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.3. Europe Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.4. Europe Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.4.1. Penicillins, By Value (2012-2022)
7.4.2. Fluoroquinolones, By Value (2012-2022)
7.4.3. Aminoglycosides, By Value (2012-2022)
7.4.4. Tetracyclines, By Value (2012-2022)
7.4.5. Macrolides, By Value (2012-2022)
7.4.6. Sulfonamides, By Value (2012-2022)
7.4.7. Lincosamides, By Value (2012-2022)
7.4.8. Cephalosporins, By Value (2012-2022)
7.4.9. Others, By Value (2012-2022)
7.5. Europe Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.5.1. Farm Animals, By Value (2012-2022)
7.5.2. Companion Animals, By Value (2012-2022)
7.6. Europe Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.6.1. Premixes, By Value (2012-2022)
7.6.2. Oral Powder, By Value (2012-2022)
7.6.3. Oral Solution, By Value (2012-2022)
7.6.4. Injections, By Value (2012-2022)
7.6.5. Others, By Value (2012-2022)
7.7. Europe Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
7.7.1. Europe Medical Gas Market, Country Share, 2012-2016 (% of Total)
7.7.2. Europe Medical Gas Market, Country Share, 2017-2022 (% of Total)
7.8. U.K. Antibiotics & Antimicrobials Market: Growth and Forecast
7.8.1. U.K. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.8.2. U.K. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.9. U.K. Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.10. U.K. Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.10.1. Penicillins, By Value (2012-2022)
7.10.2. Fluoroquinolones, By Value (2012-2022)
7.10.3. Aminoglycosides, By Value (2012-2022)
7.10.4. Tetracyclines, By Value (2012-2022)
7.10.5. Macrolides, By Value (2012-2022)
7.10.6. Sulfonamides, By Value (2012-2022)
7.10.7. Lincosamides, By Value (2012-2022)
7.10.8. Cephalosporins, By Value (2012-2022)
7.10.9. Others, By Value (2012-2022)
7.11. U.K. Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.11.1. Farm Animals, By Value (2012-2022)
7.11.2. Companion Animals, By Value (2012-2022)
7.12. U.K. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.12.1. Premixes, By Value (2012-2022)
7.12.2. Oral Powder, By Value (2012-2022)
7.12.3. Oral Solution, By Value (2012-2022)
7.12.4. Injections, By Value (2012-2022)
7.12.5. Others, By Value (2012-2022)
7.13. Germany Antibiotics & Antimicrobials Market: Growth and Forecast
7.13.1. Germany Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.13.2. Germany Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.14. Germany Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.15. Germany Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.15.1. Penicillins, By Value (2012-2022)
7.15.2. Fluoroquinolones, By Value (2012-2022)
7.15.3. Aminoglycosides, By Value (2012-2022)
7.15.4. Tetracyclines, By Value (2012-2022)
7.15.5. Macrolides, By Value (2012-2022)
7.15.6. Sulfonamides, By Value (2012-2022)
7.15.7. Lincosamides, By Value (2012-2022)
7.15.8. Cephalosporins, By Value (2012-2022)
7.15.9. Others, By Value (2012-2022)
7.16. Germany Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.16.1. Farm Animals, By Value (2012-2022)
7.16.2. Companion Animals, By Value (2012-2022)
7.17. Germany Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.17.1. Premixes, By Value (2012-2022)
7.17.2. Oral Powder, By Value (2012-2022)
7.17.3. Oral Solution, By Value (2012-2022)
7.17.4. Injections, By Value (2012-2022)
7.17.5. Others, By Value (2012-2022)
7.18. France Antibiotics & Antimicrobials Market: Growth and Forecast
7.18.1. France Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.18.2. France Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.19. France Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.20. France Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.20.1. Penicillins, By Value (2012-2022)
7.20.2. Fluoroquinolones, By Value (2012-2022)
7.20.3. Aminoglycosides, By Value (2012-2022)
7.20.4. Tetracyclines, By Value (2012-2022)
7.20.5. Macrolides, By Value (2012-2022)
7.20.6. Sulfonamides, By Value (2012-2022)
7.20.7. Lincosamides, By Value (2012-2022)
7.20.8. Cephalosporins, By Value (2012-2022)
7.20.9. Others, By Value (2012-2022)
7.21. France Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.21.1. Farm Animals, By Value (2012-2022)
7.21.2. Companion Animals, By Value (2012-2022)
7.22. France Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.22.1. Premixes, By Value (2012-2022)
7.22.2. Oral Powder, By Value (2012-2022)
7.22.3. Oral Solution, By Value (2012-2022)
7.22.4. Injections, By Value (2012-2022)
7.22.5. Others, By Value (2012-2022)
7.23. Rest of Europe Antibiotics & Antimicrobials Market: Growth and Forecast
7.23.1. Rest of Europe Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.23.2. Rest of Europe Antibiotics & Antimicrobials Market, By Value (2017-2022)
8. ASIA-PACIFIC ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
8.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.3. Asia-Pacific Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.4. Asia-Pacific Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.4.1. Penicillins, By Value (2012-2022)
8.4.2. Fluoroquinolones, By Value (2012-2022)
8.4.3. Aminoglycosides, By Value (2012-2022)
8.4.4. Tetracyclines, By Value (2012-2022)
8.4.5. Macrolides, By Value (2012-2022)
8.4.6. Sulfonamides, By Value (2012-2022)
8.4.7. Lincosamides, By Value (2012-2022)
8.4.8. Cephalosporins, By Value (2012-2022)
8.4.9. Others, By Value (2012-2022)
8.5. Asia-Pacific Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.5.1. Farm Animals, By Value (2012-2022)
8.5.2. Companion Animals, By Value (2012-2022)
8.6. Asia-Pacific Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.6.1. Premixes, By Value (2012-2022)
8.6.2. Oral Powder, By Value (2012-2022)
8.6.3. Oral Solution, By Value (2012-2022)
8.6.4. Injections, By Value (2012-2022)
8.6.5. Others, By Value (2012-2022)
8.7. Asia-Pacific Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
8.7.1. Asia-Pacific Medical Gas Market, Country Share, 2012-2016 (% of Total)
8.7.2. Asia-Pacific Medical Gas Market, Country Share, 2017-2022 (% of Total)
8.8. Japan Antibiotics & Antimicrobials Market: Growth and Forecast
8.8.1. Japan Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.8.2. Japan Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.9. Japan Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.10. Japan Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.10.1. Penicillins, By Value (2012-2022)
8.10.2. Fluoroquinolones, By Value (2012-2022)
8.10.3. Aminoglycosides, By Value (2012-2022)
8.10.4. Tetracyclines, By Value (2012-2022)
8.10.5. Macrolides, By Value (2012-2022)
8.10.6. Sulfonamides, By Value (2012-2022)
8.10.7. Lincosamides, By Value (2012-2022)
8.10.8. Cephalosporins, By Value (2012-2022)
8.10.9. Others, By Value (2012-2022)
8.11. Japan Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.11.1. Farm Animals, By Value (2012-2022)
8.11.2. Companion Animals, By Value (2012-2022)
8.12. Japan Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.12.1. Premixes, By Value (2012-2022)
8.12.2. Oral Powder, By Value (2012-2022)
8.12.3. Oral Solution, By Value (2012-2022)
8.12.4. Injections, By Value (2012-2022)
8.12.5. Others, By Value (2012-2022)
8.13. China Antibiotics & Antimicrobials Market: Growth and Forecast
8.13.1. China Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.13.2. China Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.14. China Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.15. China Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.15.1. Penicillins, By Value (2012-2022)
8.15.2. Fluoroquinolones, By Value (2012-2022)
8.15.3. Aminoglycosides, By Value (2012-2022)
8.15.4. Tetracyclines, By Value (2012-2022)
8.15.5. Macrolides, By Value (2012-2022)
8.15.6. Sulfonamides, By Value (2012-2022)
8.15.7. Lincosamides, By Value (2012-2022)
8.15.8. Cephalosporins, By Value (2012-2022)
8.15.9. Others, By Value (2012-2022)
8.16. China Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.16.1. Farm Animals, By Value (2012-2022)
8.16.2. Companion Animals, By Value (2012-2022)
8.17. China Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.17.1. Premixes, By Value (2012-2022)
8.17.2. Oral Powder, By Value (2012-2022)
8.17.3. Oral Solution, By Value (2012-2022)
8.17.4. Injections, By Value (2012-2022)
8.17.5. Others, By Value (2012-2022)
8.18. India Antibiotics & Antimicrobials Market: Growth and Forecast
8.18.1. India Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.18.2. India Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.19. India Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.20. India Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.20.1. Penicillins, By Value (2012-2022)
8.20.2. Fluoroquinolones, By Value (2012-2022)
8.20.3. Aminoglycosides, By Value (2012-2022)
8.20.4. Tetracyclines, By Value (2012-2022)
8.20.5. Macrolides, By Value (2012-2022)
8.20.6. Sulfonamides, By Value (2012-2022)
8.20.7. Lincosamides, By Value (2012-2022)
8.20.8. Cephalosporins, By Value (2012-2022)
8.20.9. Others, By Value (2012-2022)
8.21. India Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.21.1. Farm Animals, By Value (2012-2022)
8.21.2. Companion Animals, By Value (2012-2022)
8.22. India Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.22.1. Premixes, By Value (2012-2022)
8.22.2. Oral Powder, By Value (2012-2022)
8.22.3. Oral Solution, By Value (2012-2022)
8.22.4. Injections, By Value (2012-2022)
8.22.5. Others, By Value (2012-2022)
8.23. Rest of Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
8.23.1. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.23.2. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9. REST OF ASIA-PACIFIC ANTIBIOTICS & ANTIMICROBIALS MARKET, BY VALUE (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases
10. MARKET RESTRAINTS
11. CONSOLIDATION OF THE INDUSTRY
12. PORTER’S FIVE FORCES ANALYSIS – HEART VALVE DEVICES MARKET
13. SWOT ANALYSIS –HEART VALVE DEVICES MARKET
14. POLICY AND REGULATIONS
15. COMPANY PROFILES
15.1. Bayer AG
15.2. Merck & Co., Inc.;
15.3. Dechra Pharmaceuticals PLC
15.4. Boehringer Ingelheim GmbH;
15.5. Eli Lilly and Company
15.6. Ceva Sante Animale
15.7. Zoetis, Inc.
15.8. Virbac
15.9. Vetoquinol S.A.
15.10. Phibro Animal Health Corporation
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. GLOBAL ANTIBIOTICS & ANTIMICROBIALS PRODUCT OUTLOOK
5. GLOBAL ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections, By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)
6. NORTH AMERICA ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
6.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.3. North America Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.4. North America Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.4.1. Penicillins, By Value (2012-2022)
6.4.2. Fluoroquinolones, By Value (2012-2022)
6.4.3. Aminoglycosides, By Value (2012-2022)
6.4.4. Tetracyclines, By Value (2012-2022)
6.4.5. Macrolides, By Value (2012-2022)
6.4.6. Sulfonamides, By Value (2012-2022)
6.4.7. Lincosamides, By Value (2012-2022)
6.4.8. Cephalosporins, By Value (2012-2022)
6.4.9. Others, By Value (2012-2022)
6.5. North America Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.5.1. Farm Animals, By Value (2012-2022)
6.5.2. Companion Animals, By Value (2012-2022)
6.6. North America Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.6.1. Premixes, By Value (2012-2022)
6.6.2. Oral Powder, By Value (2012-2022)
6.6.3. Oral Solution, By Value (2012-2022)
6.6.4. Injections, By Value (2012-2022)
6.6.5. Others, By Value (2012-2022)
6.7. North America Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
6.7.1. North America Medical Gas Market, Country Share, 2012-2016 (% of Total)
6.7.2. North America Medical Gas Market, Country Share, 2017-2022 (% of Total)
6.8. U.S. Antibiotics & Antimicrobials Market: Growth and Forecast
6.8.1. U.S. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.8.2. U.S. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.9. U.S. Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.10. U.S. Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.10.1. Penicillins, By Value (2012-2022)
6.10.2. Fluoroquinolones, By Value (2012-2022)
6.10.3. Aminoglycosides, By Value (2012-2022)
6.10.4. Tetracyclines, By Value (2012-2022)
6.10.5. Macrolides, By Value (2012-2022)
6.10.6. Sulfonamides, By Value (2012-2022)
6.10.7. Lincosamides, By Value (2012-2022)
6.10.8. Cephalosporins, By Value (2012-2022)
6.10.9. Others, By Value (2012-2022)
6.11. U.S. Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.11.1. Farm Animals, By Value (2012-2022)
6.11.2. Companion Animals, By Value (2012-2022)
6.12. U.S. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.12.1. Premixes, By Value (2012-2022)
6.12.2. Oral Powder, By Value (2012-2022)
6.12.3. Oral Solution, By Value (2012-2022)
6.12.4. Injections, By Value (2012-2022)
6.12.5. Others, By Value (2012-2022)
6.13. Canada Antibiotics & Antimicrobials Market: Growth and Forecast
6.13.1. Canada Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.13.2. Canada Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.14. Canada Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.15. Canada Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
6.15.1. Penicillins, By Value (2012-2022)
6.15.2. Fluoroquinolones, By Value (2012-2022)
6.15.3. Aminoglycosides, By Value (2012-2022)
6.15.4. Tetracyclines, By Value (2012-2022)
6.15.5. Macrolides, By Value (2012-2022)
6.15.6. Sulfonamides, By Value (2012-2022)
6.15.7. Lincosamides, By Value (2012-2022)
6.15.8. Cephalosporins, By Value (2012-2022)
6.15.9. Others, By Value (2012-2022)
6.16. Canada Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
6.16.1. Farm Animals, By Value (2012-2022)
6.16.2. Companion Animals, By Value (2012-2022)
6.17. Canada Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.17.1. Premixes, By Value (2012-2022)
6.17.2. Oral Powder, By Value (2012-2022)
6.17.3. Oral Solution, By Value (2012-2022)
6.17.4. Injections, By Value (2012-2022)
6.17.5. Others, By Value (2012-2022)
7. EUROPE ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
7.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.3. Europe Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.4. Europe Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.4.1. Penicillins, By Value (2012-2022)
7.4.2. Fluoroquinolones, By Value (2012-2022)
7.4.3. Aminoglycosides, By Value (2012-2022)
7.4.4. Tetracyclines, By Value (2012-2022)
7.4.5. Macrolides, By Value (2012-2022)
7.4.6. Sulfonamides, By Value (2012-2022)
7.4.7. Lincosamides, By Value (2012-2022)
7.4.8. Cephalosporins, By Value (2012-2022)
7.4.9. Others, By Value (2012-2022)
7.5. Europe Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.5.1. Farm Animals, By Value (2012-2022)
7.5.2. Companion Animals, By Value (2012-2022)
7.6. Europe Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.6.1. Premixes, By Value (2012-2022)
7.6.2. Oral Powder, By Value (2012-2022)
7.6.3. Oral Solution, By Value (2012-2022)
7.6.4. Injections, By Value (2012-2022)
7.6.5. Others, By Value (2012-2022)
7.7. Europe Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
7.7.1. Europe Medical Gas Market, Country Share, 2012-2016 (% of Total)
7.7.2. Europe Medical Gas Market, Country Share, 2017-2022 (% of Total)
7.8. U.K. Antibiotics & Antimicrobials Market: Growth and Forecast
7.8.1. U.K. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.8.2. U.K. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.9. U.K. Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.10. U.K. Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.10.1. Penicillins, By Value (2012-2022)
7.10.2. Fluoroquinolones, By Value (2012-2022)
7.10.3. Aminoglycosides, By Value (2012-2022)
7.10.4. Tetracyclines, By Value (2012-2022)
7.10.5. Macrolides, By Value (2012-2022)
7.10.6. Sulfonamides, By Value (2012-2022)
7.10.7. Lincosamides, By Value (2012-2022)
7.10.8. Cephalosporins, By Value (2012-2022)
7.10.9. Others, By Value (2012-2022)
7.11. U.K. Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.11.1. Farm Animals, By Value (2012-2022)
7.11.2. Companion Animals, By Value (2012-2022)
7.12. U.K. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.12.1. Premixes, By Value (2012-2022)
7.12.2. Oral Powder, By Value (2012-2022)
7.12.3. Oral Solution, By Value (2012-2022)
7.12.4. Injections, By Value (2012-2022)
7.12.5. Others, By Value (2012-2022)
7.13. Germany Antibiotics & Antimicrobials Market: Growth and Forecast
7.13.1. Germany Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.13.2. Germany Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.14. Germany Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.15. Germany Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.15.1. Penicillins, By Value (2012-2022)
7.15.2. Fluoroquinolones, By Value (2012-2022)
7.15.3. Aminoglycosides, By Value (2012-2022)
7.15.4. Tetracyclines, By Value (2012-2022)
7.15.5. Macrolides, By Value (2012-2022)
7.15.6. Sulfonamides, By Value (2012-2022)
7.15.7. Lincosamides, By Value (2012-2022)
7.15.8. Cephalosporins, By Value (2012-2022)
7.15.9. Others, By Value (2012-2022)
7.16. Germany Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.16.1. Farm Animals, By Value (2012-2022)
7.16.2. Companion Animals, By Value (2012-2022)
7.17. Germany Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.17.1. Premixes, By Value (2012-2022)
7.17.2. Oral Powder, By Value (2012-2022)
7.17.3. Oral Solution, By Value (2012-2022)
7.17.4. Injections, By Value (2012-2022)
7.17.5. Others, By Value (2012-2022)
7.18. France Antibiotics & Antimicrobials Market: Growth and Forecast
7.18.1. France Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.18.2. France Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.19. France Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.20. France Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
7.20.1. Penicillins, By Value (2012-2022)
7.20.2. Fluoroquinolones, By Value (2012-2022)
7.20.3. Aminoglycosides, By Value (2012-2022)
7.20.4. Tetracyclines, By Value (2012-2022)
7.20.5. Macrolides, By Value (2012-2022)
7.20.6. Sulfonamides, By Value (2012-2022)
7.20.7. Lincosamides, By Value (2012-2022)
7.20.8. Cephalosporins, By Value (2012-2022)
7.20.9. Others, By Value (2012-2022)
7.21. France Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
7.21.1. Farm Animals, By Value (2012-2022)
7.21.2. Companion Animals, By Value (2012-2022)
7.22. France Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.22.1. Premixes, By Value (2012-2022)
7.22.2. Oral Powder, By Value (2012-2022)
7.22.3. Oral Solution, By Value (2012-2022)
7.22.4. Injections, By Value (2012-2022)
7.22.5. Others, By Value (2012-2022)
7.23. Rest of Europe Antibiotics & Antimicrobials Market: Growth and Forecast
7.23.1. Rest of Europe Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.23.2. Rest of Europe Antibiotics & Antimicrobials Market, By Value (2017-2022)
8. ASIA-PACIFIC ANTIBIOTICS & ANTIMICROBIALS MARKET: GROWTH AND FORECAST
8.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.3. Asia-Pacific Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.4. Asia-Pacific Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.4.1. Penicillins, By Value (2012-2022)
8.4.2. Fluoroquinolones, By Value (2012-2022)
8.4.3. Aminoglycosides, By Value (2012-2022)
8.4.4. Tetracyclines, By Value (2012-2022)
8.4.5. Macrolides, By Value (2012-2022)
8.4.6. Sulfonamides, By Value (2012-2022)
8.4.7. Lincosamides, By Value (2012-2022)
8.4.8. Cephalosporins, By Value (2012-2022)
8.4.9. Others, By Value (2012-2022)
8.5. Asia-Pacific Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.5.1. Farm Animals, By Value (2012-2022)
8.5.2. Companion Animals, By Value (2012-2022)
8.6. Asia-Pacific Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.6.1. Premixes, By Value (2012-2022)
8.6.2. Oral Powder, By Value (2012-2022)
8.6.3. Oral Solution, By Value (2012-2022)
8.6.4. Injections, By Value (2012-2022)
8.6.5. Others, By Value (2012-2022)
8.7. Asia-Pacific Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
8.7.1. Asia-Pacific Medical Gas Market, Country Share, 2012-2016 (% of Total)
8.7.2. Asia-Pacific Medical Gas Market, Country Share, 2017-2022 (% of Total)
8.8. Japan Antibiotics & Antimicrobials Market: Growth and Forecast
8.8.1. Japan Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.8.2. Japan Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.9. Japan Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.10. Japan Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.10.1. Penicillins, By Value (2012-2022)
8.10.2. Fluoroquinolones, By Value (2012-2022)
8.10.3. Aminoglycosides, By Value (2012-2022)
8.10.4. Tetracyclines, By Value (2012-2022)
8.10.5. Macrolides, By Value (2012-2022)
8.10.6. Sulfonamides, By Value (2012-2022)
8.10.7. Lincosamides, By Value (2012-2022)
8.10.8. Cephalosporins, By Value (2012-2022)
8.10.9. Others, By Value (2012-2022)
8.11. Japan Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.11.1. Farm Animals, By Value (2012-2022)
8.11.2. Companion Animals, By Value (2012-2022)
8.12. Japan Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.12.1. Premixes, By Value (2012-2022)
8.12.2. Oral Powder, By Value (2012-2022)
8.12.3. Oral Solution, By Value (2012-2022)
8.12.4. Injections, By Value (2012-2022)
8.12.5. Others, By Value (2012-2022)
8.13. China Antibiotics & Antimicrobials Market: Growth and Forecast
8.13.1. China Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.13.2. China Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.14. China Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.15. China Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.15.1. Penicillins, By Value (2012-2022)
8.15.2. Fluoroquinolones, By Value (2012-2022)
8.15.3. Aminoglycosides, By Value (2012-2022)
8.15.4. Tetracyclines, By Value (2012-2022)
8.15.5. Macrolides, By Value (2012-2022)
8.15.6. Sulfonamides, By Value (2012-2022)
8.15.7. Lincosamides, By Value (2012-2022)
8.15.8. Cephalosporins, By Value (2012-2022)
8.15.9. Others, By Value (2012-2022)
8.16. China Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.16.1. Farm Animals, By Value (2012-2022)
8.16.2. Companion Animals, By Value (2012-2022)
8.17. China Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.17.1. Premixes, By Value (2012-2022)
8.17.2. Oral Powder, By Value (2012-2022)
8.17.3. Oral Solution, By Value (2012-2022)
8.17.4. Injections, By Value (2012-2022)
8.17.5. Others, By Value (2012-2022)
8.18. India Antibiotics & Antimicrobials Market: Growth and Forecast
8.18.1. India Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.18.2. India Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.19. India Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.20. India Antibiotics & Antimicrobials & Market- By Product Type, By Value (2012-2022)
8.20.1. Penicillins, By Value (2012-2022)
8.20.2. Fluoroquinolones, By Value (2012-2022)
8.20.3. Aminoglycosides, By Value (2012-2022)
8.20.4. Tetracyclines, By Value (2012-2022)
8.20.5. Macrolides, By Value (2012-2022)
8.20.6. Sulfonamides, By Value (2012-2022)
8.20.7. Lincosamides, By Value (2012-2022)
8.20.8. Cephalosporins, By Value (2012-2022)
8.20.9. Others, By Value (2012-2022)
8.21. India Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
8.21.1. Farm Animals, By Value (2012-2022)
8.21.2. Companion Animals, By Value (2012-2022)
8.22. India Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.22.1. Premixes, By Value (2012-2022)
8.22.2. Oral Powder, By Value (2012-2022)
8.22.3. Oral Solution, By Value (2012-2022)
8.22.4. Injections, By Value (2012-2022)
8.22.5. Others, By Value (2012-2022)
8.23. Rest of Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
8.23.1. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.23.2. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9. REST OF ASIA-PACIFIC ANTIBIOTICS & ANTIMICROBIALS MARKET, BY VALUE (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases
10. MARKET RESTRAINTS
11. CONSOLIDATION OF THE INDUSTRY
12. PORTER’S FIVE FORCES ANALYSIS – HEART VALVE DEVICES MARKET
13. SWOT ANALYSIS –HEART VALVE DEVICES MARKET
14. POLICY AND REGULATIONS
15. COMPANY PROFILES
15.1. Bayer AG
15.2. Merck & Co., Inc.;
15.3. Dechra Pharmaceuticals PLC
15.4. Boehringer Ingelheim GmbH;
15.5. Eli Lilly and Company
15.6. Ceva Sante Animale
15.7. Zoetis, Inc.
15.8. Virbac
15.9. Vetoquinol S.A.
15.10. Phibro Animal Health Corporation
LIST OF FIGURES
Figure 1: Global Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 3: Live Animal Production, 2010-2014
Figure 4: World Meat Consumption Projections, Million Tones, (2017-2026)
Figure 5: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 6: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 7: Global Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 8: Global Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 9: Global Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 10: North America Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 11: North America Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 12: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 13: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 14: North America Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 15: North America Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 16: North America Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 17: North America Elevators and Escalators Market, Country Share, 2012-2016 (% of Total)
Figure 18: North America Elevators and Escalators Market, Country Share, 2017-2022 (% of Total)
Figure 19: U.S. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 20: Number of households owning pets in millions
Figure 21: Consumption of BEEF Meat in U.S., In Thousand Tones, 2012-2016
Figure 22: Consumption PIG Meat in U.S., In Thousand Tones, 2012-2016
Figure 23: Consumption of Sheep Meat in U.S., In Thousand Tones, 2012-2016
Figure 24: Consumption of Poultry Meat in U.S., In Thousand Tones, 2012-2016
Figure 25: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 26: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 27: U.S. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 28: U.S. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 29: U.S. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 30: Canada Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 31: Estimated Farm Output of Hogs (X 1000), 2012-2016
Figure 32: Estimated Farm Output of Sheep & Lambs (X 1000), 2012-2016
Figure 33: Canadian Pet Dogs and Cat Population, 2012-2016
Figure 34: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 35: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 36: Canada Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 37: Canada Animal Antibiotics & Antimicrobials Market- By Animal Type Type, By Value, 2012-2022, (USD Million)
Figure 38: Canada Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 39: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 40: Europe household owing at least one cat or dog-2014
Figure 41: Europe household owing atleast one cat or dog -2015
Figure 42: Pet Ownership Statistics Europe and European Union, 2016
Figure 43: Number of Dairy Cows, EU (28 Countries), 1000 heads 2012-2016
Figure 44: Number of Bovine Animals, 1000 heads, EU (28 countries) 2012-2016
Figure 45: Number of Pigs, EU (28 Countries), 1000 heads, 2012-2016
Figure 46: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 47: Europe Animal Antibiotics & Antimicrobials Market Share Analysis, By Key Players, 2016
Figure 48: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 49: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 50: Europe Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 51: Europe Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 52: Europe Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 53: Europe Antibiotics & Antimicrobials Market, Country Share, 2012-2016 (% of Total)
Figure 54: Europe Elevators Antibiotics & Antimicrobials Market, Country Share, 2017-2022 (% of Total)
Figure 55: U.K. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 56: Cattle on Agriculture Holdings as on 1st December, 2012-2016
Figure 57: Sheep and Lambs on UK agricultural holdings as on 1st June, 2012-2016
Figure 58: Pigs on Agriculture Holdings as on 1st December, 2012-2016
Figure 59: Poultry on UK agricultural holdings as on 1st June, 2012-2016
Figure 60: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 61: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 62: U.K. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 63: U.K. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 64: U.K. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 65: Germany Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 66: Pet Ownership in Germany in millions
Figure 67: Share of households owing pet in Germany
Figure 68: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 69: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 70: Germany Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 71: Germany Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 72: Germany Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 73: France Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 74: Pet Ownership in France in millions
Figure 75: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 76: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 77: France Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 78: France Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 79: France Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 80: Rest of Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 81: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 82: China – Pet ownership
Figure 83: Hong Kong – Pet ownership
Figure 84: Buffaloes Population in Asia, 2012-2014
Figure 85: Cattle Population in Asia, 2012-2014
Figure 86: Goats Population in Asia, 2012-2014
Figure 87: Sheep Population in Asia, 2012-2014
Figure 88: Pigs Population in Asia, 2012-2014
Figure 89: Horses Population in Asia, 2012-2014
Figure 90: Ducks Population (1,000 heads) in Asia, 2012-2014
Figure 91: Chicken Population (1,000 heads) in Asia, 2012-2014
Figure 92: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 93: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 94: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 95: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 96: Asia-Pacific Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 97: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 98: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2012-2016 (% of Total)
Figure 99: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2017-2022 (% of Total)
Figure 100: Japan Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 101: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 102: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 103: Japan – Pet ownership
Figure 104: Japan Spending on Pets in Yen
Figure 105: Japan Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 106: Japan Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 107: Japan Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 108: China Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 109: China Livestock Statistics, 2012-2014
Figure 110: China Livestock Statistics, 2012-2014
Figure 111: Chickens & Ducks (1000 heads), 2012-2014
Figure 112: China pet ownership- 2015
Figure 113: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 114: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 115: China Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 116: China Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 117: China Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 118: India Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 119: India Livestock Statistics, 2012-2014
Figure 120: India Livestock Population Statistics, 2012-2014
Figure 121: India Chickens Population Statistics (1000 heads), 2012-2014
Figure 122: Meat Consumption, (Thousand Tones) 2012-2016
Figure 123: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 124: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 125: India Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 126: India Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 127: India Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 128: Rest of Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 129: World Meat Consumption, Million Tones, (2012-2016)
Figure 130: Market Share of Global leading players in Animal Antimicrobials & Antibiotics Market, 2016 (%)
Figure 131: Net Sales, By Business Segment, % Share 2016
Figure 132: Net Sales, By Sub Segment, Life Science, % Share 2016
Figure 133: Net Revenue, By Geographic Location, % Share 2016
Figure 134: Net Product Sales& Service Revenue, 2012-2016 (In million USD)
Figure 135: Net Sales, By Geographic Location, % Share 2016
Figure 136: Net Revenue, By Business Segment, % Share 2016
Figure 137: Net Sales, 2012-2016 (In million USD)
Figure 138: Net Revenue, By Product Category, % Share 2016
Figure 139: Net Revenue, By Geographic Location, % Share 2016
Figure 140: Net Sales, 2012-2016 (In million USD)
Figure 141: Net Sales, 2012-2016 (In million USD)
Figure 142: Net Revenue, By Geographic Location, % Share 2016
Figure 143: Net Revenue, By Business Segment Category, % Share 2016
Figure 144: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 145: Net Revenue, By Business Segment Category, % Share 2016
Figure 146: Net Revenue, By Geographic Location, % Share 2016
Figure 147: Net Sales, 2012-2016 (In million USD)
Figure 148: Net Revenue, By Business Segment Category, % Share 2016
Figure 149: Net Sales, 2012-2016 (In million USD)
Figure 150: Net Sales, 2012-2016 (In million USD)
Figure 151: Net Revenue, By Geographic Location, % Share 2016
Figure 152: Net Revenue, By Species, % Share 2016
Figure 153: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 154: Revenue, By Product Consideration, % Share 2016
Figure 155: Net Sales, 2012-2016 (In million USD)
Figure 156: Net Revenue, By Geographic Location, % Share 2016
Figure 157: Net Revenue, By Type of Animal, % Share 2016
Figure 158: Net Revenue, By Product Category, Companion Animal, % Share 2016
Figure 159: Revenue, By Product Category, Farm Animal, % Share 2016
Figure 160: Net Sales, 2015-2016 (In million USD)
Figure 161: Net Sales, By Geographic Region, % Share 2015-2016 (In million USD)
Figure 162: Net Sales, 2012-2016 (In million USD)
Figure 163: Net Revenue, By Geographic Location, % Share 2016
Figure 164: Net Sales, By Business Segment, % Share 2016
Figure 165: Net Sales, By Product Group, Animal Health, % Share 2016
Figure 1: Global Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 3: Live Animal Production, 2010-2014
Figure 4: World Meat Consumption Projections, Million Tones, (2017-2026)
Figure 5: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 6: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 7: Global Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 8: Global Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 9: Global Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 10: North America Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 11: North America Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 12: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 13: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 14: North America Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 15: North America Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 16: North America Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 17: North America Elevators and Escalators Market, Country Share, 2012-2016 (% of Total)
Figure 18: North America Elevators and Escalators Market, Country Share, 2017-2022 (% of Total)
Figure 19: U.S. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 20: Number of households owning pets in millions
Figure 21: Consumption of BEEF Meat in U.S., In Thousand Tones, 2012-2016
Figure 22: Consumption PIG Meat in U.S., In Thousand Tones, 2012-2016
Figure 23: Consumption of Sheep Meat in U.S., In Thousand Tones, 2012-2016
Figure 24: Consumption of Poultry Meat in U.S., In Thousand Tones, 2012-2016
Figure 25: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 26: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 27: U.S. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 28: U.S. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 29: U.S. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 30: Canada Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 31: Estimated Farm Output of Hogs (X 1000), 2012-2016
Figure 32: Estimated Farm Output of Sheep & Lambs (X 1000), 2012-2016
Figure 33: Canadian Pet Dogs and Cat Population, 2012-2016
Figure 34: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 35: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 36: Canada Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 37: Canada Animal Antibiotics & Antimicrobials Market- By Animal Type Type, By Value, 2012-2022, (USD Million)
Figure 38: Canada Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 39: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 40: Europe household owing at least one cat or dog-2014
Figure 41: Europe household owing atleast one cat or dog -2015
Figure 42: Pet Ownership Statistics Europe and European Union, 2016
Figure 43: Number of Dairy Cows, EU (28 Countries), 1000 heads 2012-2016
Figure 44: Number of Bovine Animals, 1000 heads, EU (28 countries) 2012-2016
Figure 45: Number of Pigs, EU (28 Countries), 1000 heads, 2012-2016
Figure 46: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 47: Europe Animal Antibiotics & Antimicrobials Market Share Analysis, By Key Players, 2016
Figure 48: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 49: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 50: Europe Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 51: Europe Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 52: Europe Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 53: Europe Antibiotics & Antimicrobials Market, Country Share, 2012-2016 (% of Total)
Figure 54: Europe Elevators Antibiotics & Antimicrobials Market, Country Share, 2017-2022 (% of Total)
Figure 55: U.K. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 56: Cattle on Agriculture Holdings as on 1st December, 2012-2016
Figure 57: Sheep and Lambs on UK agricultural holdings as on 1st June, 2012-2016
Figure 58: Pigs on Agriculture Holdings as on 1st December, 2012-2016
Figure 59: Poultry on UK agricultural holdings as on 1st June, 2012-2016
Figure 60: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 61: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 62: U.K. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 63: U.K. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 64: U.K. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 65: Germany Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 66: Pet Ownership in Germany in millions
Figure 67: Share of households owing pet in Germany
Figure 68: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 69: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 70: Germany Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 71: Germany Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 72: Germany Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 73: France Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 74: Pet Ownership in France in millions
Figure 75: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 76: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 77: France Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 78: France Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 79: France Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 80: Rest of Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 81: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 82: China – Pet ownership
Figure 83: Hong Kong – Pet ownership
Figure 84: Buffaloes Population in Asia, 2012-2014
Figure 85: Cattle Population in Asia, 2012-2014
Figure 86: Goats Population in Asia, 2012-2014
Figure 87: Sheep Population in Asia, 2012-2014
Figure 88: Pigs Population in Asia, 2012-2014
Figure 89: Horses Population in Asia, 2012-2014
Figure 90: Ducks Population (1,000 heads) in Asia, 2012-2014
Figure 91: Chicken Population (1,000 heads) in Asia, 2012-2014
Figure 92: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 93: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 94: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 95: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 96: Asia-Pacific Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 97: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 98: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2012-2016 (% of Total)
Figure 99: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2017-2022 (% of Total)
Figure 100: Japan Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 101: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 102: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 103: Japan – Pet ownership
Figure 104: Japan Spending on Pets in Yen
Figure 105: Japan Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 106: Japan Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 107: Japan Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 108: China Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 109: China Livestock Statistics, 2012-2014
Figure 110: China Livestock Statistics, 2012-2014
Figure 111: Chickens & Ducks (1000 heads), 2012-2014
Figure 112: China pet ownership- 2015
Figure 113: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 114: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 115: China Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 116: China Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 117: China Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 118: India Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 119: India Livestock Statistics, 2012-2014
Figure 120: India Livestock Population Statistics, 2012-2014
Figure 121: India Chickens Population Statistics (1000 heads), 2012-2014
Figure 122: Meat Consumption, (Thousand Tones) 2012-2016
Figure 123: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 124: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 125: India Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 126: India Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 127: India Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 128: Rest of Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 129: World Meat Consumption, Million Tones, (2012-2016)
Figure 130: Market Share of Global leading players in Animal Antimicrobials & Antibiotics Market, 2016 (%)
Figure 131: Net Sales, By Business Segment, % Share 2016
Figure 132: Net Sales, By Sub Segment, Life Science, % Share 2016
Figure 133: Net Revenue, By Geographic Location, % Share 2016
Figure 134: Net Product Sales& Service Revenue, 2012-2016 (In million USD)
Figure 135: Net Sales, By Geographic Location, % Share 2016
Figure 136: Net Revenue, By Business Segment, % Share 2016
Figure 137: Net Sales, 2012-2016 (In million USD)
Figure 138: Net Revenue, By Product Category, % Share 2016
Figure 139: Net Revenue, By Geographic Location, % Share 2016
Figure 140: Net Sales, 2012-2016 (In million USD)
Figure 141: Net Sales, 2012-2016 (In million USD)
Figure 142: Net Revenue, By Geographic Location, % Share 2016
Figure 143: Net Revenue, By Business Segment Category, % Share 2016
Figure 144: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 145: Net Revenue, By Business Segment Category, % Share 2016
Figure 146: Net Revenue, By Geographic Location, % Share 2016
Figure 147: Net Sales, 2012-2016 (In million USD)
Figure 148: Net Revenue, By Business Segment Category, % Share 2016
Figure 149: Net Sales, 2012-2016 (In million USD)
Figure 150: Net Sales, 2012-2016 (In million USD)
Figure 151: Net Revenue, By Geographic Location, % Share 2016
Figure 152: Net Revenue, By Species, % Share 2016
Figure 153: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 154: Revenue, By Product Consideration, % Share 2016
Figure 155: Net Sales, 2012-2016 (In million USD)
Figure 156: Net Revenue, By Geographic Location, % Share 2016
Figure 157: Net Revenue, By Type of Animal, % Share 2016
Figure 158: Net Revenue, By Product Category, Companion Animal, % Share 2016
Figure 159: Revenue, By Product Category, Farm Animal, % Share 2016
Figure 160: Net Sales, 2015-2016 (In million USD)
Figure 161: Net Sales, By Geographic Region, % Share 2015-2016 (In million USD)
Figure 162: Net Sales, 2012-2016 (In million USD)
Figure 163: Net Revenue, By Geographic Location, % Share 2016
Figure 164: Net Sales, By Business Segment, % Share 2016
Figure 165: Net Sales, By Product Group, Animal Health, % Share 2016
LIST OF TABLES
Table A: Food producing Animal & poultry Production, 100 Heads 2010-2014
Table B: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table C: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table D: Livestock Statistics Inventories, July 2017
Table E: Holding with cattle and stock of cattle, 2016/17
Table F: Holding with Pigs and stock of Pigs, 2016/17
Table G: Holding with Sheep and stock of Sheep, 2016/17
Table H: Holding with Poultry and stock of Poultry, 2016/17
Table I: Germany Farm Animal Statistics, 2016-2017
Table J: Bovine/Cattle Statistics, (Heads), 2015-2016
Table K: Regulations for the use of antimicrobials in Livestock for growth promotion
Table L: Antibiotics Prohibited for Extra-label use in Food Animals by FDA as of April 1, 2015
Table M: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)
Table N: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)
Table A: Food producing Animal & poultry Production, 100 Heads 2010-2014
Table B: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table C: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table D: Livestock Statistics Inventories, July 2017
Table E: Holding with cattle and stock of cattle, 2016/17
Table F: Holding with Pigs and stock of Pigs, 2016/17
Table G: Holding with Sheep and stock of Sheep, 2016/17
Table H: Holding with Poultry and stock of Poultry, 2016/17
Table I: Germany Farm Animal Statistics, 2016-2017
Table J: Bovine/Cattle Statistics, (Heads), 2015-2016
Table K: Regulations for the use of antimicrobials in Livestock for growth promotion
Table L: Antibiotics Prohibited for Extra-label use in Food Animals by FDA as of April 1, 2015
Table M: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)
Table N: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)
